Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, featuring promising enhancements across a variety of clinical and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, much more trustworthy alternate for therapeutic use,